Revenue + Forward P/E
Hims & Hers Health, Inc. (HIMS) quarterly revenue and forward P/EForward P/E: 67.2x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$6.44B
Enterprise value
$8.20B
P/E ratio (TTM)
-654.00x
P/S ratio (TTM)
3.08x
P/B ratio
16.74x
EV/Sales
3.46x
EV/EBITDA
272.96x
Dividend yield
0.00%
Income statement (TTM)
Revenue (TTM)
$2.35B
Gross profit (TTM)
$1.73B
Operating income (TTM)
$105.61M
EBITDA (TTM)
$178.43M
Net income (TTM)
$128.37M
Free cash flow (TTM)
$73.96M
Margins & returns
Gross margin
67.64%
Operating margin
1.32%
Profit margin
-0.56%
Return on equity
-2.48%
Return on assets
-0.58%
Per-share metrics
EPS (TTM)
-$0.06
Dividend yield
0.00%
Beta
2.34
Capital structure
Cash & equivalents
$228.62M
Total debt
$1.12B
Net debt
$891.97M
Shares outstanding
223.08M
Financial health
Current ratio
1.90
Debt / equity
2.07
Debt / assets
0.52
Interest coverage
-
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $630.14B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $443.33B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.40B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $354.73B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.49B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $6.44B | -654.00x | 3.08x | 272.96x | - |